IMMR Q3 2025 Earnings EPS Beat Drives Positive Market Reaction Licensing Revenue Remains Opaque OCUL Q1 2026 Earnings WiderThanExpected Loss as Ocular Therapeutix Advances Pipeline WLDN Q1 2026 Earnings Earnings Beat Drives Stock Rally OKTA Q1 2026 Earnings EPS Beat Drives Positive Market Reaction Dominari Holdings Q1 2024 Earnings Widening Losses Reflect Ongoing Investment in Pipeline ATLCZ Q1 2026 Earnings Strong EPS Beat Highlights Resilient Credit Operations